7,8-DIHYDRO-7,7-DIMETHYL-2-(N,N-DIMETHYLAMINOMETHYLENEAMINO)-6-[2-(N-METHOXY-N-METHYLCARBAMOYL)-VINYL]-PTERIDIN-4(3H)-ONE
Compound with spectra: 1 NMR
![7,8-DIHYDRO-7,7-DIMETHYL-2-(N,N-DIMETHYLAMINOMETHYLENEAMINO)-6-[2-(N-METHOXY-N-METHYLCARBAMOYL)-VINYL]-PTERIDIN-4(3H)-ONE](/api/compound/HQmhoA1ahdk.png?ph=true&h=300&w=458 "7,8-DIHYDRO-7,7-DIMETHYL-2-(N,N-DIMETHYLAMINOMETHYLENEAMINO)-6-[2-(N-METHOXY-N-METHYLCARBAMOYL)-VINYL]-PTERIDIN-4(3H)-ONE")
| SpectraBase Compound ID | HQmhoA1ahdk |
|---|---|
| InChI | InChI=1S/C16H23N7O3/c1-16(2)10(7-8-11(24)23(5)26-6)18-12-13(21-16)19-15(20-14(12)25)17-9-22(3)4/h7-9H,1-6H3,(H2,19,20,21,25)/b8-7+,17-9+ |
| InChIKey | LVVXPTAPKUHHBJ-ITDUAQOSSA-N |
| Mol Weight | 361.41 g/mol |
| Molecular Formula | C16H23N7O3 |
| Exact Mass | 361.186238 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
7,8-DIHYDRO-7,7-DIMETHYL-2-PIVALOYLAMINO-6-(2-METHYLCARBONYLVINYL)-PTERIDIN-4(3H)-ONE
7,8-DIHYDRO-7,7-DIMETHYL-2-PIVALOYLAMINO-6-(2-ETHOXYCARBONYLVINYL)-PTERIDIN-4(3H)-ONE
7,8-DIHYDRO-7,7-DIMETHYL-2-PIVALOYLAMINO-6-(2-METHOXYCARBONYLETHYL)-PTERIDIN-4(3H)-ONE
6-(4-Bromophenyl)-8,9-dihydro-3-methyl-2-morpholino-3H-pyrimido[4,5-b][1,4]diazepin-4(7H)-one
2-(Benzylamino)-6-(4-chlorophenyl)-8,9-dihydro-3-methyl-3H-pyrimido[4,5-b][1,4]diazepin-4(7H)-one
2-(Benzylamino)-8,9-dihydro-3-methyl-6-p-tolyl-3H-pyrimido[4,5-b][1,4]diazepin-4(7H)-one
2-(Benzylamino)-6-(4-bromophenyl)-8,9-dihydro-3-methyl-3H-pyrimido[4,5-b][1,4]diazepin-4(7H)-one
6-METHYLENECARBOXYMETHYL-3-METHYL-2-METHYLTHIOPTERIDINE-4,7(3H,8H)-DIONE
9-(CYCLOPENT-2-ENYL)-8-OXOGUANINE
12-METHYL-HYDROGEN-11,12-SECOPODOCARPA-8,13-DIENE-11,12-DIOATE
| Title | Journal or Book | Year |
|---|---|---|
| Specific inhibitors in vitamin biosynthesis. Part 11. Syntheses of pterins with extended side chains at C-6 | Journal of the Chemical Society, Perkin Transactions 1 | 1999 |